Xinxin Gan

168 Changhai Rd
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

A prediction model for targeted drug resistance in renal cell carcinoma based on plasma proteomics analysis.

A prediction model for targeted drug resistance in renal cell carcinoma based on plasma proteomics analysis.

Journal: Translational andrology and urology

Published: January 14, 2026

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).

Journal: ESMO open

Published: July 11, 2025

Single-cell transcriptomics identifies SOCS3+ exhausted T cells as a biomarker facilitating clear cell renal cell carcinoma progression.

Single-cell transcriptomics identifies SOCS3+ exhausted T cells as a biomarker facilitating clear cell renal cell carcinoma progression.

Journal: Clinical and experimental medicine

Published: June 03, 2025

CD70: An emerging target for integrated cancer diagnosis and therapy.

CD70: An emerging target for integrated cancer diagnosis and therapy.

Journal: Clinical and translational medicine

Published: February 27, 2025

Causal impact of genetically determined metabolites on kidney cancer and its subtypes: an integrated mendelian randomization and metabolomic study.

Causal impact of genetically determined metabolites on kidney cancer and its subtypes: an integrated mendelian randomization and metabolomic study.

Journal: American journal of cancer research

Published: February 14, 2025

Integrated transcriptome analysis and combinatorial machine learning to construct a homeostatic model of acetylation for ccRCC and validate the key gene GCNT4.

Integrated transcriptome analysis and combinatorial machine learning to construct a homeostatic model of acetylation for ccRCC and validate the key gene GCNT4.

Journal: Cancer cell international

Published: February 11, 2025

Function and mechanism of lactylation in health and diseases: a comprehensive review.

Function and mechanism of lactylation in health and diseases: a comprehensive review.

Journal: International journal of surgery (London, England)

Published: February 04, 2025

Association of body mass index with clinicopathological features among patients with clear cell renal cell carcinoma treated with surgery: a retrospective study.

Association of body mass index with clinicopathological features among patients with clear cell renal cell carcinoma treated with surgery: a retrospective study.

Journal: Scientific reports

Published: August 30, 2024

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 20, 2024

LDHA-mediated M2-type macrophage polarization via tumor-derived exosomal EPHA2 promotes renal cell carcinoma progression.

LDHA-mediated M2-type macrophage polarization via tumor-derived exosomal EPHA2 promotes renal cell carcinoma progression.

Journal: Molecular carcinogenesis

Published: January 22, 2024

Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.

Tumor cell-intrinsic SETD2 inactivation sensitizes cancer cells to immune checkpoint blockade through the NR2F1-STAT1 pathway.

Journal: Journal for immunotherapy of cancer

Published: November 16, 2023

Research progress of the Hippo signaling pathway in renal cell carcinoma.

Research progress of the Hippo signaling pathway in renal cell carcinoma.

Journal: Asian journal of urology

Published: August 23, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026